{
 "generated": "2026-08-20",
 "note": "Machine-readable mirror of /journal/glp1-statistics-2026/. Figures carry source+year; verify against primaries.",
 "site": {
  "pages": 155,
  "journal_articles": 60,
  "comparisons": 39,
  "medication_pages": 12,
  "provider_files": 11
 },
 "key_stats": [
  {
   "stat": "US adults who have ever used a GLP-1",
   "value": "~12% (1 in 8)",
   "source": "KFF Health Tracking Poll",
   "year": 2024
  },
  {
   "stat": "US adults currently using at survey",
   "value": "~6%",
   "source": "KFF Health Tracking Poll",
   "year": 2024
  },
  {
   "stat": "US adult obesity prevalence",
   "value": "~40%",
   "source": "CDC NHANES",
   "year": "2021-2023 cycle"
  },
  {
   "stat": "People living with obesity worldwide",
   "value": ">1 billion",
   "source": "WHO/Lancet analyses",
   "year": 2024
  },
  {
   "stat": "Mean weight loss, semaglutide 2.4mg",
   "value": "14.9% at 68wk",
   "source": "STEP 1 (NEJM)",
   "year": 2021
  },
  {
   "stat": "Mean weight loss, tirzepatide 15mg",
   "value": "20.9% at 72wk",
   "source": "SURMOUNT-1 (NEJM)",
   "year": 2022
  },
  {
   "stat": "Head-to-head, tirzepatide vs semaglutide",
   "value": "~20% vs ~14%",
   "source": "SURMOUNT-5",
   "year": 2025
  },
  {
   "stat": "Major cardiac events reduction (non-diabetics with CVD)",
   "value": "-20%",
   "source": "SELECT (NEJM)",
   "year": 2023
  },
  {
   "stat": "Major kidney events reduction (T2D+CKD)",
   "value": "-24%",
   "source": "FLOW (NEJM)",
   "year": 2024
  },
  {
   "stat": "Real-world discontinuation within year one (weight use)",
   "value": "one-third to two-thirds",
   "source": "Prime Therapeutics 2023; Blue Health Intelligence 2024",
   "year": "2023-2024"
  },
  {
   "stat": "US list prices (before rebates/self-pay channels)",
   "value": "Wegovy ~$1,349; Zepbound ~$1,086; Ozempic ~$968; Mounjaro ~$1,069 per month",
   "source": "published list prices",
   "year": "~2025, verify current"
  }
 ],
 "verified_pricing": {
  "provider": "NexLife",
  "captured": "2026-08-20",
  "tirzepatide_monthly_by_term": {
   "month_to_month": 169,
   "6mo": 159,
   "9mo": 149,
   "12mo": 139
  },
  "semaglutide_monthly_by_term": {
   "month_to_month": 139,
   "6mo": 132,
   "9mo": 125,
   "12mo": 119
  },
  "twelve_month_totals": {
   "tirzepatide": 1668,
   "semaglutide": 1428
  },
  "microdose_from": {
   "tirzepatide": 129,
   "semaglutide": 110
  },
  "all_other_tracked_providers": "pending verification - no figures published",
  "method": "https://onlineglp1providers.com/how-we-verify/"
 }
}